Browse by Day

Thursday, 6 December 2012

Thursday | Friday | Saturday | Sunday | top

09:00 - 10:30

Postgraduate Course 1: ANAPHYLAXIS TRACK - Evaluation, Management and Prevention of Anaphylaxis
G.01 (HICC)
 Chairpersons: K. Kanak Rao (India) Anirban Maitra (India)
09:00 - 09:05
Welcoming Remarks
09:05 - 09:20
1-1PG: Understanding and Recognizing Anaphylactic Reactions | Richard F. Lockey (United States)
09:20 - 09:35
1-2PG: Diagnostic Tests and Differential Diagnosis | Dana Wallace (United States)
09:35 - 09:50
1-3PG: Acute Management and Follow-Up Strategies | F. Estelle R. Simons (Canada)
09:50 - 10:30
Discussion
Postgraduate Course 2: ASTHMA AND LOWER AIRWAY DISEASE TRACK - Biomarkers, Lung Function and Bronchial Provocation Tests of Asthma
G.02 (HICC)
 Chairpersons: Vijai Kumar Ratnavelu (India)
09:00 - 09:05
Welcoming Remarks
09:05 - 09:20
2-1PG: Biomarkers Such as Exhaled NO and Sputum Eosinophils | Peter Le Souëf (Australia)
09:20 - 09:35
2-2PG: Assessing Lung Function | Randeep Guleria (India)
09:35 - 09:50
2-3PG: Bronchial Provocation | Lanny J. Rosenwasser (United States)
09:50 - 10:30
Discussion
Postgraduate Course 3: DRUG ALLERGY TRACK - Practical Approaches to Aspirin and NSAID Hypersensitivity
G.03 (HICC)
 Chairpersons: Young Joo Cho (South Korea) , Carsten Bindslev-Jensen (Denmark)
09:00 - 09:05
Welcoming Remarks
09:05 - 09:20
3-1PG: Classification and Pathophysiology of Aspirin Hypersensitivity | Mario Sanchez Borges (Venezuela)
09:20 - 09:35
3-2PG: Diagnostic Testing | Hiok Hee Chng (Singapore)
09:35 - 09:50
3-3PG: Prevention and Management | Hae-Sim Park (South Korea)
09:50 - 10:30
Discussion
Postgraduate Course 4: UPPER AIRWAY ALLERGIES TRACK - Objective Assessment of Upper Airway Diseases: Hands-on Rhinolaryngoscopy and Nasal Challenge Tests
G.04 (HICC)
 Chairpersons: Peter W. Hellings (Belgium) , Katsuhisa Ikeda (Japan)
09:00 - 09:05
Welcoming Remarks
09:05 - 09:20
4-1PG: Nasal Challenge Testing | Ruby Pawankar (Japan)
09:20 - 09:35
4-2PG: Imaging | Claus Bachert (Belgium)
09:35 - 09:50
4-3PG: Nasal Endoscopy: Practical Aspects | Nishit Shah (India)
09:50 - 10:30
Discussion
Postgraduate Course 5: FOOD ALLERGY TRACK - Food Allergy Over the Life Course: From Childhood to Adulthood
G.05 (HICC)
 Chairpersons: Amal Assa'ad (US) , Kyu-Earn Kim (South Korea)
09:00 - 09:05
Welcoming Remarks
09:05 - 09:20
5-1PG: Allergy to Wheat, an Alarming Type of Food Allergy in the Asia-Pacific | Pakit Vichyanond (Thailand)
09:20 - 09:35
5-2PG: Natural Course of Pediatric Food Allergy | Hugo Van Bever (Singapore)
09:35 - 09:50
5-3PG: Oral Allergy Syndrome and Food Induced Anaphylaxis | Richard Weber (United States)
09:50 - 10:30
Discussion
Postgraduate Course 6: IMMUNOTHERAPY TRACK - Allergy Testing In-Vivo and In-Vitro
G.06 (HICC)
 Chairpersons: Chaweewan Bunnag (Thailand) , Karnen Baratawidjaja (Indonesia)
09:00 - 09:05
Welcoming Remarks
09:05 - 09:20
6-1PG: Interpretation of In-Vitro | Ignacio J. Ansotegui (Spain)
09:20 - 09:35
6-2PG: Interpretation of In-Vivo | Sandra Gonzalez-Diaz (Mexico)
09:35 - 09:50
6-3PG: Development of Diagnosis and Treatment Based on Testing | TBC
09:50 - 10:30
Discussion

11:00 - 12:30

Postgraduate Course 7: ANAPHYLAXIS TRACK - Causes of Anaphylaxis
G.01 (HICC)
 Chairpersons: VS Advani (India) , Margitta Worm (Germany)
11:00 - 11:05
Welcoming Remarks
11:05 - 11:20
7-1PG: Overview of Pathophysiology of Anaphylaxis | Margitta Worm (Germany)
11:20 - 11:35
7-2PG: Conditions that Predispose Anaphylaxis | Sandra Gonzalez-Diaz (Mexico)
11:35 - 11:50
7-3PG: Anaphylaxis in Vulnerable Patients | Mario Sanchez Borges (Venezuela)
11:50 - 12:30
Discussion
Postgraduate Course 8: ASTHMA AND LOWER AIRWAY DISEASE TRACK - Improving Patient’s Asthma Control and Quality of Life
G.02 (HICC)
 Chairpersons: Arvind Bhome (India) , William Silvers (US)
11:00 - 11:05
Welcoming Remarks
11:05 - 11:20
8-1PG: Compliance and Treatment Adherence | Michael Blaiss (United States)
11:20 - 11:35
8-2PG: Improving Patient’s Quality of Life | Vijai Kumar Ratnavelu (India)
11:35 - 11:50
8-3PG: Implementation of Guidelines and Assessing Asthma Control | K.S. Satish (India)
11:50 - 12:30
Discussion
Postgraduate Course 9: DRUG ALLERGY TRACK - Drug Allergy Evaluation and Management of Beta Lactam Allergy
G.03 (HICC)
 Chairpersons: Hae-Sim Park (South Korea) , Jung-Won Park (South Korea)
11:00 - 11:05
Welcoming Remarks
11:05 - 11:20
9-1PG: Patterns of Cross Reactivity | Werner Pichler (Switzerland)
11:20 - 11:35
9-2PG: Clinical Presentation and Diagnosis | Carsten Bindslev-Jensen (Denmark)
11:35 - 11:50
9-3PG: Desensitization Protocols | Hiok Hee Chng (Singapore)
11:50 - 12:30
Discussion
Postgraduate Course 10: UPPER AIRWAY ALLERGIES TRACK - Practical Aspects of Managing Upper Airway Allergies
G.04 (HICC)
 Chairpersons: Nishit Shah (India) , Joong Saeng Cho (South Korea)
11:00 - 11:05
Welcoming Remarks
11:05 - 11:20
10-1PG: Managing Rhinitis and Co-morbidities in Children | Meenu Singh (India)
11:20 - 11:35
10-2PG: Managing Rhinosinusitis in Children | Elham Hossny (Egypt)
11:35 - 11:50
10-3PG: Managing Rhinitis and Co-morbidities in Adults | Pendakur Anand (India)
11:50 - 12:30
Discussion
Postgraduate Course 11: FOOD ALLERGY TRACK - Food Allergy: Other Forms of Food Allergy
G.05 (HICC)
 Chairpersons: Pakit Vichyanond (Thailand) , Anne Goh (Singapore)
11:00 - 11:05
Welcoming Remarks
11:05 - 11:20
11-1PG: Eosinophilic Esophagitis Update | Hugh Sampson (United States)
11:20 - 11:35
11-2PG: Eosinophilic Gastroentrocolitis | Amal Assa'ad (United States)
11:35 - 11:50
11-3PG: Other Non- IgE Mediated Food Allergies | Katie Allen (Australia)
11:50 - 12:30
Discussion
Postgraduate Course 12: IMMUNOTHERAPY TRACK - Practical Aspects of Immunotherapy
G.06 (HICC)
 Chairpersons: Hugo Van Bever (Singapore) , Nelson Rosario-Filho (Brazil)
11:00 - 11:05
Welcoming Remarks
11:05 - 11:20
12-1PG: Nuts and Bolts of Allergy Skin Testing | Nelson Rosario-Filho (Brazil)
11:20 - 11:35
12-2PG: How to Write an Allergen Immunotherapy Prescription | Hugo Van Bever (Singapore)
11:35 - 11:50
12-3PG: Selection and Preparation of Allergen Extracts | Richard F. Lockey (United States)
11:50 - 12:30
Discussion

13:30 - 15:00

Postgraduate Course 13: ALLERGY, ASTHMA AND SLEEP DISORDERS TRACK - Gastroesophageal Reflux Disease (GERD)
G.01 (HICC)
 Chairpersons: Neelam Mohan (India) , Sergio Bonini (Italy)
13:30 - 13:35
Welcoming Remarks
13:35 - 13:50
13-1PG: Clinical Signs and Symptoms | Neelam Mohan (India)
13:50 - 14:05
13-2PG: Clinical and Laboratory Diagnosis | Richard Weber (United States)
14:05 - 14:20
13-3PG: Impact of the GE Reflux on Upper Airways Diseases | Fernan Caballero - Fonseca (Venezuela)
14:20 - 15:00
Discussion
Postgraduate Course 14: ASTHMA AND LOWER AIRWAY DISEASE TRACK - Asthma Exacerbations: Treatment and Prevention
G.02 (HICC)
 Chairpersons: G.C. Khilnani (India) , Joong Saeng Cho (South Korea)
13:30 - 13:35
Welcoming Remarks
13:35 - 13:50
14-1PG: Risk Factors, Triggers and Pathways for Asthma Exacerbations | Carlos E. Baena-Cagnani (Argentina)
13:50 - 14:05
14-2PG: Acute Management and Prevention | Raj B. Singh (India)
14:05 - 14:20
14-3PG: Managing Virus-Induced Wheezing in Children | Stanley Fineman (United States)
14:20 - 15:00
Discussion
Postgraduate Course 15: ATOPIC DERMATITIS TRACK - Managing Severe and Refractory Atopic Dermatitis
G.03 (HICC)
 Chairpersons: Bok-Yang Pyun (South Korea) , Kiran Godse (India)
13:30 - 13:35
Welcoming Remarks
13:35 - 13:50
15-1PG: Atopic Dermatitis in Food Allergy | Pakit Vichyanond (Thailand)
13:50 - 14:05
15-2PG: Role of Immunomodulators in Treatment | Bee Wah Lee (Singapore)
14:05 - 14:20
15-3PG: Complications that Require Intervention | Tatiana Slavyanskaya (Russia)
14:20 - 15:00
Discussion
Postgraduate Course 16: URTICARIA & ANGIOEDEMA TRACK - Understanding and Managing Acute and Chronic Urticaria
G.04 (HICC)
 Chairpersons: Konrad Bork (Germany) , Sarbjit Saini (US)
13:30 - 13:35
Welcoming Remarks
13:35 - 13:50
16-1PG: Classification and Pathophysiology of Urticaria and Angioedema | Sarbjit Saini (United States)
13:50 - 14:05
16-2PG: Diagnostic Approach and Treatment | Jonathan Bernstein (United States)
14:05 - 14:20
16-3PG: Approach to Refractory Urticaria and Angioedema | Michihiro Hide (Japan)
14:20 - 15:00
Discussion
Postgraduate Course 17: FOOD ALLERGY TRACK - Recent Advances in Diagnosis and Oral Food Challenge Test
G.05 (HICC)
 Chairpersons: Katie Allen (Australia) , Michael Levin (South Africa)
13:30 - 13:35
Welcoming Remarks
13:35 - 13:50
17-1PG: Component Reseolved Diagnostic (CRD) | Motohiro Ebisawa (Japan)
13:50 - 14:05
17-2PG: Basophil Activation Markers | Takao Fujisawa (Japan)
14:05 - 14:20
17-3PG: Oral Food Challenge | Alessandro Fiocchi (Italy)
14:20 - 15:00
Discussion
Postgraduate Course 18: IMMUNOTHERAPY TRACK - Managing Adverse Reactions to Immunotherapy
G.06 (HICC)
 Chairpersons: Pendakur Anand (India) , G. Walter Canonica (Italy) , Ranbir Kaulsay (Ireland)
13:30 - 13:35
Welcoming Remarks
13:35 - 13:50
18-1PG: Understand the Difference between Local and Systemic Reactions | Michael Blaiss (United States)
13:50 - 14:05
18-2PG: Avoiding Adverse Reactions | Giovanni Passalacqua (Italy)
14:05 - 14:20
18-3PG: Managing Adverse Reactions | Roy Gerth Van Wijk (Netherlands)
14:20 - 15:00
Discussion

15:30 - 17:00

Postgraduate Course 19: ALLERGY, ASTHMA AND SLEEP DISORDERS TRACK - Sleep Workshop
G.01 (HICC)
 Chairpersons: Fernan Caballero - Fonseca (Venezuela) , Sanjeev Mehta (India) , Ajit Vigg (India)
15:30 - 15:35
Welcoming Remarks
15:35 - 15:50
19-1PG: Clinical Signs and Symptoms of Sleep Apnea | Peter Le Souëf (Australia)
15:50 - 16:05
19-2PG: Evaluating a Patient with Sleep Apnea | Jyotsna Joshi (India)
16:05 - 16:20
19-3PG: Practical Aspects of Treatment and Outcomes | J.C. Suri (India)
16:20 - 17:00
Discussion
Postgraduate Course 20: INHALATION DEVICES TRACK
G.02 (HICC)
 Chairpersons: Michael J. Abramson (Australia) , Michael Blaiss (US)
15:30 - 15:35
Welcoming Remarks
15:35 - 15:50
20-1PG: Inhalation Devices in the US | Michael Blaiss (United States)
15:50 - 16:05
20-2PG: Inhalation Devices in India | Sujeet Rajan (India)
16:05 - 16:20
20-3PG: Inhalation Devices in the Far East | Takao Fujisawa (Japan)
16:20 - 17:00
Discussion
Postgraduate Course 21: ATOPIC DERMATITIS TRACK - Understanding and Managing Atopic Dermatitis
G.03 (HICC)
 Chairpersons: Tatiana Slavyanskaya (Russia) , Fares Zaitoun (Lebanon)
15:30 - 15:35
Welcoming Remarks
15:35 - 15:50
21-1PG: Overview of Pathogenesis | Thomas Bieber (Germany)
15:50 - 16:05
21-2PG: Diagnosis and Treatment | Bok-Yang Pyun (South Korea)
16:05 - 16:20
21-3PG: Practical Issues in Skin Care | Carsten Bindslev-Jensen (Denmark)
16:20 - 17:00
Discussion
Postgraduate Course 22: URTICARIA & ANGIOEDEMA TRACK - Diagnosis and Treatment of Hereditary Angioedema (HAE)
G.04 (HICC)
 Chairpersons: Jonathan Bernstein (US) , Ramesh B. Ramaiah (India)
15:30 - 15:35
Welcoming Remarks
15:35 - 15:50
22-1PG: Definition and Mechanisms of HAE | Konrad Bork (Germany)
15:50 - 16:05
22-2PG: Diagnosis and Differential Diagnosis of HAE | Connie Katelaris (Australia)
16:05 - 16:20
22-3PG: Acute and Prophylactic Management | Michihiro Hide (Japan)
16:20 - 17:00
Discussion
Postgraduate Course 23: FOOD ALLERGY TRACK - Practical Management of Food Allergy and Oral Desensitization
G.05 (HICC)
 Chairpersons: Jiu-Yao Wang (Taiwan) , Motohiro Ebisawa (Japan)
15:30 - 15:35
Welcoming Remarks
15:35 - 15:50
23-1PG: Regional Perspectives | Bee Wah Lee (Singapore)
15:50 - 16:05
23-2PG: Practical Management of Food Allergy | Motohiro Ebisawa (Japan)
16:05 - 16:20
23-3PG: Oral Immunotherapy | Wesley Burks (United States)
16:20 - 17:00
Discussion
Postgraduate Course 24: IMMUNOTHERAPY TRACK - Hands-On Demonstration of Allergen Preparation and Use
G.06 (HICC)
 Chairpersons: Ignacio J. Ansotegui (Spain) , Nagendra Komarla (India)
15:30 - 15:35
Welcoming Remarks
15:35 - 15:50
24-1PG: Live Demonstration of Skin Prick Testing and Intradermal | Dana Wallace (United States)
15:50 - 16:05
24-2PG: Correlation of Testing with Challenge Data | Roy Gerth Van Wijk (Netherlands)
16:05 - 16:20
24-3PG: Comparison of Preparation of SCIT vs SLIT | Giovanni Passalacqua (Italy)
16:20 - 17:00
Discussion

Friday, 7 December 2012

Thursday | Friday | Saturday | Sunday | top

08:00 - 09:30

Plenary Session 1: The Origins of Allergy
Hall 3 (HICC)
 Chairpersons: Lanny J. Rosenwasser (US) , K.S. Satish (India)
08:00 - 08:05
Welcoming Remarks
08:05 - 08:30
1-1PS: New Insights into the Developmental Origins of Allergy | Susan Prescott (Australia)
08:30 - 08:55
1-2PS: Role of Tissues in Immune Tolerance Development in the Early Life | Cezmi Akdis (Switzerland)
08:55 - 09:20
1-3PS: How Much Can be Explained by Genetics and Epigenetics? | Stephen T. Holgate (United Kingdom)
09:20 - 09:30
Discussion

10:00 - 11:45

Symposium 1: WAO-APAPARI Session: Food Allergy and Gastrointestinal (GI) Tract
Hall 3 (HICC)
 Chairpersons: Mona Al-Ahmad (Kuwait) , Jing-Long Huang (Taiwan) , Neelam Mohan (India)
10:00 - 10:05
Welcoming Remarks
10:05 - 10:25
1-1SY: Development of the GI Immune System and Oral Tolerance | Wesley Burks (United States)
10:25 - 10:45
1-2SY: The Role of Dietary Nutrients in the Predisposition and Modulation of the Allergic Response | Susan Prescott (Australia)
10:45 - 11:05
1-3SY: GI Manifestations of Food Allergy – Facts and Controversies | Hugh Sampson (United States)
11:05 - 11:25
1-4SY: Component Analysis for Diagnosis | Motohiro Ebisawa (Japan)
11:25 - 11:45
Discussion

10:00 - 11:30

Symposium 2: Severe Upper Airways Disease
Hall 1 and 2 (HICC)
 Chairpersons: Yuzhi Chen (China) , Nishit Shah (India)
10:00 - 10:05
Welcoming Remarks
10:05 - 10:25
2-1SY: Mechanisms of Upper Airway Inflammation | Ruby Pawankar (Japan)
10:25 - 10:45
2-2SY: Upper Airway Barrier Function and Microbiome | Claus Bachert (Belgium)
10:45 - 11:05
2-3SY: Severe Rhinosinusitis | Robert Naclerio (United States)
11:05 - 11:30
Discussion
Symposium 3: EAACI-WAO World Allergy and Asthma Congress – Milan 2013: Immune Effector Mechanisms and Immune Tolerance in Allergic Disease
Hall 5 and 6 (HICC)
 Chairpersons: Cezmi Akdis (Switzerland) , Dhiman Ganguly (India)
10:00 - 10:05
Welcoming Remarks
10:05 - 10:25
3-1SY: Cellular and Molecular Mechanisms of Allergen Tolerance | Mübeccel Akdis (Switzerland)
10:25 - 10:45
3-2SY: Inflammatory Mediators of Allergic Asthma | Lanny J. Rosenwasser (United States)
10:45 - 11:05
3-3SY: Inflammatory Biomarkers in Severe Asthma | Stephen T. Holgate (United Kingdom)
11:05 - 11:30
Discussion

11:45 - 12:15

Keynote Lecture 1: The Role of Translational Research in Addressing Health Disparities
Hall 3 (HICC)
 Chairperson: Ruby Pawankar (Japan)
11:45 - 11:50
Welcoming Remarks
11:50 - 12:15
1-1KN: Speaker | Vishwa Mohan Katoch (India)

12:15 - 12:45

Keynote Lecture 2: European Respiratory Roadmap
Hall 3 (HICC)
 Chairperson: Stephen T. Holgate (United Kingdom)
12:15 - 12:20
Welcoming Remarks
12:20 - 12:45
2-1KN: Speaker | Klaus Rabe (Germany)

12:45 - 14:15

Plenary Session 2: Food Allergy
Hall 3 (HICC)
 Chairpersons: Hugo Van Bever (Singapore) , Alessandro Fiocchi (Italy)
12:45 - 12:50
Welcoming Remarks
12:50 - 13:15
2-1PS: Severe Food Allergy - Prediction and Approach to Treatment | Hugh Sampson (United States)
13:15 - 13:40
2-2PS: WAO Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) and Worldwide Food Allergy Guidelines | Alessandro Fiocchi (Italy)
13:40 - 14:05
2-3PS: Prevention of Food Allergy: Is it Feasible? | Motohiro Ebisawa (Japan)
14:05 - 14:15
Discussion

14:45 - 16:50

Symposium 6: The Environment and Occupational Allergies
Hall 5 and 6 (HICC)
 Chairpersons: Jae-Won Oh (South Korea) , Young-Koo Jee (South Korea)
14:45 - 14:50
Welcoming Remarks
14:50 - 15:10
6-1SY: Occupational Airway Diseases | Roy Gerth Van Wijk (Netherlands)
15:10 - 15:30
6-2SY: Genetic and Environmental Factors in the Etiology of Occupational Asthma | Hae-Sim Park (South Korea)
15:30 - 15:50
6-3SY: Indoor and Outdoor Air Pollutants | Michael J. Abramson (Australia)
15:50 - 16:10
6-4SY: Biodiversity | Tari Haahtela (Finland)
16:10 - 16:30
6-5SY: Climate Change and Allergy | Gennaro D'Amato (Italy)
16:30 - 16:50
Discussion

14:45 - 16:30

Symposium 4: Life Altering Allergic Disorders
Hall 3 (HICC)
 Chairpersons: Thomas Bieber (Germany) , Carla Irani (Lebanon)
14:45 - 14:50
Welcoming Remarks
14:50 - 15:10
4-1SY: Hereditary Angioedema | Konrad Bork (Germany)
15:10 - 15:30
4-2SY: Eosinophilic Esophagitis | Amal Assa'ad (United States)
15:30 - 15:50
4-3SY: Mastocytosis | F. Estelle R. Simons (Canada)
15:50 - 16:10
4-4SY: ICON Lecture on Eosinophilic Disorders | Lanny J. Rosenwasser (United States)
16:10 - 16:30
Discussion
Symposium 5: Severe Ocular Allergies
Hall 1 and 2 (HICC)
 Chairpersons: Sunita Kanumury (US)
14:45 - 14:50
Welcoming Remarks
14:50 - 15:10
5-1SY: Pathophysiology of Ocular Allergies | Dana Wallace (United States)
15:10 - 15:30
5-2SY: Differential Diagnosis in Severe Ocular Allergies | Sergio Bonini (Italy)
15:30 - 15:50
5-3SY: Nasal Ocular Connections in Allergic Rhinoconjunctivitis | Robert Naclerio (United States)
15:50 - 16:10
5-4SY: Treatment Options in Ocular Allergies | Connie Katelaris (Australia)
16:10 - 16:30
Discussion

16:30 - 17:30

Poster Session 1-1: Asthma Diagnosis and Treatment 1
Hall 4 (HICC)
 Chairpersons: Carlos E. Baena-Cagnani (Argentina) , Raja Dhar (India)
1001
1001: Identification of Prevalent Sensitizing Allergens in India | Shubnum Singh (India)
1002
1002: Title:FEF25-75%: A More Sensitive Indicator in the Early Detection of Asthma | Marzieh Tavakol (Iran)
1003
1003: Severe Asthma: A Comparision of Clinical Severity and Lung Function | Raja Dhar (India)
1004
1004: The Utility of Mannitol Challenge in the Assessment of Asthma | Dario Antolin-Amerigo (Spain)
1005
1005: Optimization for the Withdrawal of Inhaled Corticosteroid Treatment by Monitoring Fractional Exhaled Nitric Oxide (FeNO) and Lung Functions | Morimitsu Tomikawa (Japan)
1006
1006: Perillae Semen Abolished Allergic Asthmatic Response in Murine Model | Mi-Kyeong Kim (South Korea)
1007
1007: Clinical Application of Forced Oscillation Technique for Children with Asthma | Keigo Kainuma (Japan)
1008
1008: Is Small Airways Disease A Widely Prevalent Yet Underdiagnosed Phenotype of Asthma and COPD in India? | Sandeep Tandon (India)
1009
1009: A Clinical Studyof NE–C900 (OMRON) Nebulizer | Jose Ouseph (India)
1010
1010: Lung Function Tests in Exercise-Induced Asthma Among a Pediatric Population | Silvia Sanchez Garcia (Spain)
1011
1011: Ozac - A Herbal Medicine for Bronchial Asthma | Hari Kishan Gonuguntla (India)
1012
1012: The Efficacy of Budesonide in the Treatment of Acute Asthma in Children: A Double-Blind, Randomized, Controlled Trial | Abdullah A. Alangari (Saudi Arabia)
1013
1013: Six Months Follow up of Pediatric Patients With Severe Persistent Allergic Asthma After One Year Omalizumab Therapy | Tarun Choudhuri (India)
1014
1014: Single Center Experience of 4 Cases of Diffuse Panbronchiolitis Clinically Presented as Treatment Resistant Asthma | Jung-Won Park (South Korea)
1015
1015: Improvements in lung function in an Indian Population with IgE mediated asthma receiving Omalizumab in a real-world setting | Randeep Guleria (India)
Poster Session 1-2: Asthma Diagnosis and Treatment 2
Hall 4 (HICC)
 Chairpersons: Mario Castro (US) , Saleh Al Muhsen (Saudi Arabia)
1016
1016: Is Atopy in People Aged 40 and Over Related to Fixed Airflow Obstruction? | Michael J. Abramson (Australia)
1017
1017: Prevalence and Determinants of Allergy and Asthma Amongst Indian Children | Sheetu Singh (India)
1018
1018: Effect of Inhaled Corticosteroids with Long-Acting beta2 Agonists Vs. Inhaled Corticosteroid Alone On Asthma Control in Children: Results From National Asthma Survey | Richard F. Lockey (United States)
1019
1019: Churg Strauss Syndrome - Missed Diagnosis and Consequences | Mahomed Cassim Kamdar (South Africa)
1021
1021: Prevalence of Wheezing and Risk Factor of Asthma in Preschool Children, South Korea | Sung-Il Woo (South Korea)
1022
1022: The Differences of Clinical Profiles by Houst Dust Mite Sensitization in Patients with Asthmatics in Soonchunhyang University Hospital Cohort | An-Soo Jang (South Korea)
1023
1023: The Implementation of Asthma Management Guideline and the Obstacle Factors in Korea | Yoon-Seok Chang (South Korea)
1024
1024: Prevalence of Depression Among Asthma Patients & Effects of Asthma Control On Severity of Depression | Swapnendu Misra (India)
1025
1025: Prevalence of Childhood Asthma in Small City of Iran: An ISAAC Study | Shaghayegh Sadat Noorani Hassan Kiadeh (Iran)
1026
1026: Long Term Twice Weekly Dose of Methotrextate in Steroid Dependent Chronic Allergic Diseases Kumar, Suman | Poonam Kumar (India)
1027
1027: Body Mass Index of Asthmatic Children in United Arab Emirates | Suleiman Al-Hammadi (United Arab Emirates)
1028
1028: A rare case of bronchial asthma and allergic rhinitis with complete right lung agenesis investigated in tertiary case hospital | Ram Awadh Singh Kushwaha (India)
1029
1029: Yoga as an Adjuvant Therapy in Asthma Management | Surya Kant (India)
Poster Session 1-3: Environmental and Occupational Respiratory Diseases 1
Hall 4 (HICC)
 Chairpersons: Mika Mäkelä (Finland) , Wayne Thomas (Australia)
1030
1030: Role of Fungi (Molds) in Allergic Airway Disease – an Analysis in a South Indian Otolaryngology Center | Vattikonda Sathavahana Chowdary (India)
1031
1031: A Study of Outdoor Aeroallergens in Riyadh, Saudi Arabia | Syed Mohammed Hasnain (Saudi Arabia)
1032
1032: Study of Allergen Pattern in Cases of Chronic Allergic Rhinitis in Central India | Subir Jain (India)
1033
1033: Rust Fungi of Plants and High IgE Levels in Asymptomatic Workers of a Stored Food Grains Godown : A Possible Relationship | Satadal Das (India)
1034
1034: A Novel ELISA Method for the Detection of Dust Mite Allergens Using Igy Technology | Eduardo Egea (Colombia)
1035
1035: Isolation and Purification of Major Allergenic Protein of Moth and Rice Weevil Insect Extracts | Mohd Adnan Kausar (India)
1036
1036: Preliminary Audit of the Allergy Clinic and Spectrum of Aeroallergen Sensitivity in Allergic Rhinitis | Soumya M.S. (India)
1037
1037: Sensitization to Indoor Aeroallergens in Pediatric Patients | Claudia Gallego-Corella (Mexico)
Poster Session 1-4: Environmental and Occupational Respiratory Diseases 2
Hall 4 (HICC)
 Chairpersons: Elham Hossny (Egypt) , Roy Gerth Van Wijk (Netherlands)
1038
1038: Efficacy of Influenza Vaccination On Pediatric Asthma Control | Mohammad Reza Fazlollahi (Iran)
1039
1039: Clinical Course and Side Effects of Anti-IgE Monoclonal Antibody in Patients with Severe Persistent Asthma | Arzu Didem Yalcin (Turkey)
1040
1040: Associations Between Asthma and Bronchial Hyper-Responsiveness with Allergy and Atopy Phenotypes in Urban Black South African Teenagers | Michael Levin (South Africa)
1041
1041: The Evaluation of the Role of Obesity On Adults with Bronchial Asthma | Tanja Grzetic-Romcevic (Slovenia)
1042
1042: Influence of Environmental Endotoxin and Allergen Levels On Prevalence of Asthma and Allergen Sensitizations in Urban and Rural Children in Guangdong, China | Mulin Feng (China)
1043
1043: Effects of Socio-Economic Status, Life Style Patterns and Demographic Factors On the Onset of Asthma Among Adult Brahmins in Delhi., India | Monika Bhuker (India)
1044
1044: Prevalence of Recurrent Wheezing in Infants in a Poor Urban City in South Brazil | Marilyn Urrutia Pereira (Brazil)
1045
1045: Skin Prick Tests and Allergen-Specific IgE Tests for Fungus in Patients with Chronic Lower Respiratory Symptoms | Byoung Whui Choi (South Korea)
1046
1046: Lung Function Among the Workers Exposed to Rubber Factory in West Bengal | Naren Pandey (India)
1047
1047: Trend of Asthma and Attention Deficit– A 5-Year Population Survey | Kuo-Wei Yeh (Taiwan)
1048
1048: Association of VDR SNPs with Allergy Asthma in Colombian Caribbean Patients. A Pilot Study | Eduardo Egea (Colombia)
1049
1049: Impacts of Air Pollution and Environmental Tobacco Smoking On the Symptoms of Childhood Asthma | Chang Sun Sim (South Korea)
Poster Session 1-5: Environmental and Occupational Respiratory Diseases 3
Hall 4 (HICC)
 Chairpersons: S.K. Chhabra (India) , Gennaro D'Amato (Italy)
1050
1050: Determination of Immunoglobulin E In Asthmatic Workers with Respiratory Infections of Al-Baiji Oil Refinery In Iraq | Mohemid Al-Jebouri (Iraq)
1051
1051: Intractable Sneezing - Case Report | Vattikonda Sathavahana Chowdary (India)
1052
1052: Airway Mucus Hypersecretion And Its Management Through Exercises | Manikonda Prakash Rao (India)
1053
1053: Plastic Bags- A Double Edge Sword | Deepika Ramachandra (India)
1054
1054: Sensitization to Storage Mites, Wheat and Yeast Allergens in Cuban Bakers | Mirta Alvarez Castello (Cuba)
1055
1055: CD23, Th1/Th2 Cytokines in Children with Bronchial Asthma, Bronchiolitis and Bronchial Pneumonia | Anchoju Vijayendra Chary (India)
1056
1056: Enhancement of Sensitivity for Human Airway Epithelial Cells to House Dust Mites by Respiratory Syncytial Virus Infection | Woo-Sung Chang (South Korea)
1057
1057: Correlation Between Air Pollution and Respiratory Health of School Children in Delhi | Jincy Mathew (India)
1058
1058: Clinical and Diagnostic Characteristics of Mycoplasma Pneumoniae Pneumonia in Children with Lobar Pneumonia | Jae Ho Lee (South Korea)
1059
1059: Lung Exposure to TiO2 Induces Eosinophilic Airway Inflammation in the Rabbits | Gil-Soon Choi (South Korea)
1060
1060: Clinical Responses to Methylprednisolone PULSE Therapy in Children with Severe Refractory Mycoplasma Pneumoniae Pneumonia | Jae Ho Lee (South Korea)
1061
1061: The Change of Eosinophil, Serum Level of ECP, and Interleukin-5 During Mycoplasma Pneumoniae Infection in Atopic Children | Jae-Won Oh (South Korea)
1062
1062: The Climate and Aero Allergens in Mediterranean Region and Allergen Sensitivity in Allergic Rhinoconjunctivitis and Allergic Asthma Patients | Arzu Didem Yalcin (Turkey)
1063
1063: Spirometric Abnormalities in Non Smoking Bus Drivers of Hyderabad | Mohammed Faisal (India)
Poster Session 1-6: Mechanisms of Asthma and Allergic Disease 1
Hall 4 (HICC)
 Chairpersons: S.K. Jindal (India) , Fernan Caballero - Fonseca (Venezuela)
1064
1064: Interleukin 31 (IL 31) Serum Levels In Atopic Dermatitis Patients | Noor Suryani Mohd Ashari (Malaysia)
1065
1065: Association Between Level of Serum IL 31 and IL 33 and Pruritus in Malaysian Allergic Patients | Noor Suryani Mohd Ashari (Malaysia)
1066
1066: Ceruloplasmin Oxidase Activity in Allergic Asthma and Allergic Rhinitis | Arzu Didem Yalcin (Turkey)
1068
1068: Why We Should Not Use Steroids Against Infections in Infants with Atopic Dermatitis | Akiyoshi Yamanaka (Japan)
1069
1069: Down Regulation of IL-13 Secretion in Mononuclear Cells by a Beta-Adrenergic Blocker | Fatemeh Hajighasemi (Iran)
1070
1070: Genetic Mechanisms of Immune Imbalance in Allergic Inflammation | Uktam Ziyadullaev (Uzbekistan)
1071
1071: Chemokines From Cord Blood Mononuclear Cells and the Development of Eczema or Wheeze At 2 Years of Age in Infants At High Risk for Atopy | Phaik Ling Quah (Singapore)
1072
1072: CD48: A Novel Biomarker for Asthma? | Yael Minai-Fleminger (Israel)
1073
1073: Image Analyses and Cell Activation of Der p2 in Human Epithelium | Jawji Tsai (Taiwan)
1074
1074: Prebiotics in Infants for Prevention of Allergic Disease and Food Hypersensitivity | John Sinn (Australia)
1075
1075: Probiotics in Infants for Prevention of Allergic Disease and Food Hypersensitivity | John Sinn (Australia)
1076
1076: Identification of Genes Related to Seasonal Allergic Rhinitis by Microarray Analysis | Yoshimasa Imoto (Japan)
1077
1077: Differential Expression and Roles of MMP-2, MMP-9, MMP-13, TIMP-1, and TIMP-2 in Allergic Rhinitis | Sachiko Mori (Japan)
1078
1078: Determination of Nitric Oxide Levels From a Single Breath, in Indian Asthmatic Children | Asha Pherwani (India)
Poster Session 1-7: Mechanisms of Asthma and Allergic Disease 2
Hall 4 (HICC)
 Chairpersons: Carla Irani (Lebanon) , John Sinn (Australia)
1079
1079: Evidence of Platelet Activation in Asthmatic Patients | Hyun Jung Jin (South Korea)
1080
1080: Interactive Effect of Sodium Sulfite and Rhinovirus Infection in Chemokines Production by Airway Epithelial Cells | Hyun Hee Kim (South Korea)
1081
1081: Resolvin Inhibits the Cryopyrin/Nalp3 Inflammasome | Narasaiah Kolliputi (United States)
1082
1082: Relevance of IL-17A to Eosinopil Accumulation and Mucosal Remodeling in Chronic Rhinosinusitis with Nasal Polyps | Katsuhisa Ikeda (Japan)
1083
1083: CD23, Total IgE and Th1/Th2 Cytokines in Asthma Patients | Anchoju Vijayendra Chary (India)
1084
1084: Localization and up-Regulation of CysLT2 Receptor in Perennial Allergic Rhinitis | Hideaki Shirasaki (Japan)
1085
1085: Safety and Tolerability of Escalating Doses of House Dust Mite Peptide Antigen Desensitisation | Roderick Peter Hafner (United Kingdom)
1086
1086: Bacteria-Derived Extracellular Vesicles As an Important Causative Agent for Asthma and COPD | Young-Koo Jee (South Korea)
1087
1087: Serine Protease Activity of Per a 10 Is Required to Activate Airway Epithelial Cells | Sagar Laxman Kale (India)
1088
1088: Increased Serum Strail Level in Newly Diagnosed Stage-Iv Lung Adenocarcinoma but Not Squamous Cell Carcinoma, Is Correlated with Age and Smoking | Arzu Didem Yalcin (Turkey)
1089
1089: The Effect of the Gender of the Fetus On the Control of Asthma During Pregnancy | Mohamed Helmi Zidan (Egypt)
1090
1090: Eosinophils Enhance Airway Smooth Muscle Cell Proliferation Via the Release of Cystl Leukotrines | Saleh Al Muhsen (Saudi Arabia)
1091
1091: Eosinophilia Nasal Impact Over the Lung Function Tests in Patients with Moderate to Severe Persistent Allergic Rhinitis | Claudia Ivonne Gallego (Mexico)
1092
1092: Regulation of Profibrotic Cytokines Release From Human Eosinophils by Th17 Cytokines | Saleh Al Muhsen (Saudi Arabia)
1093
1093: A Novel Human Anti-VCAM-1Monoclonal Antibody Ameliorates Airway Inflammation and Remodeling in Murine Asthma Model | Jung-Won Park (South Korea)
1094
1094: Pre-clinical characterization of RP3133, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders | Kasi Viswanath Routhu (India)

Saturday, 8 December 2012

Thursday | Friday | Saturday | Sunday | top

08:00 - 09:30

Plenary Session 3: Severe Asthma
Hall 3 (HICC)
 Chairpersons: You-Young Kim (South Korea) , Ashok Mahashur (India)
08:00 - 08:05
Welcoming Remarks
08:05 - 08:30
3-1PS: Severe Asthma Phenotypes in Adults | Rohit K. Katial (United States)
08:30 - 08:55
3-2PS: Severe Asthma Characteristics in Pediatrics | Peter Le Souëf (Australia)
08:55 - 09:20
3-3PS: Therapeutic Interventions in Severe Asthma | Thomas B. Casale (United States)
09:20 - 09:30
Discussion

10:00 - 12:00

Symposium 8: Confounders of Asthma Treatment
Hall 2 (HICC)
 Chairpersons: Narayan Mishra (India) , Tatiana Slavyanskaya (Russia)
10:00 - 10:05
Welcoming Remarks
10:05 - 10:25
8-1SY: Vocal Cord Dysfunction (VCD) | Rohit K. Katial (United States)
10:25 - 10:45
8-2SY: Gastroesophageal Reflux Disease (GERD) | Richard F. Lockey (United States)
10:45 - 11:05
8-3SY: Rhinosinusitis / Nasal Polyps | Claus Bachert (Belgium)
11:05 - 11:25
8-4SY: Allergic Bronchopulmonary Aspergillosis (ABPA) | Ashok Shah (India)
11:25 - 11:45
8-5SY: Difficult to Treat Asthma in the Indian Context | Zarir Udwadia (India)
11:45 - 12:00
Discussion

10:00 - 11:45

Company Sponsored Symposium 1: Sanofi: Managing Airways Diseases in 2012
Hall 1 (HICC)
 Chairperson: Randeep Guleria (India)
10:00 - 10:05
Welcoming Remarks
10:05 - 10:35
1-1CSS: The Impact of Allergic Rhinitis on Asthma - The Asian Perspective | Ruby Pawankar (Japan)
10:35 - 11:05
1-2CSS: Allergic Respiratory Diseases and its Co morbidities: The Real Clinical Practice | Carlos E. Baena-Cagnani (Argentina)
11:05 - 11:35
1-3CSS: From the Mediators to the Patient | G. Walter Canonica (Italy)
11:35 - 11:45
Panel Discussion
Symposium 9: Severe Adverse Reactions to Drugs
Hall 5 and 6 (HICC)
 Chairpersons: Hiok Hee Chng (Singapore) , Jaideep Gogtay (India)
10:00 - 10:05
Welcoming Remarks
10:05 - 10:25
9-1SY: Pathomechanisms of Severe Drug Allergy | Werner Pichler (Switzerland)
10:25 - 10:45
9-2SY: Severe Reactions to Beta Lactam Antibiotics | Carsten Bindslev-Jensen (Denmark)
10:45 - 11:05
9-3SY: Allergic Reactions to Biological and Chemotherapeutic Drugs | Mario Sanchez Borges (Venezuela)
11:05 - 11:25
9-4SY: Management of Aspirin and NSAID Hypersensitivity | Hae-Sim Park (South Korea)
11:25 - 11:45
Discussion

10:00 - 11:30

Symposium 7: Childhood Asthma
Hall 3 (HICC)
 Chairpersons: Stanley Fineman (US) , Elham Hossny (Egypt)
10:00 - 10:05
Welcoming Remarks
10:05 - 10:25
7-1SY: Early Viral Infections: Their Role in the Development of Asthma | Nelson Rosario-Filho (Brazil)
10:25 - 10:45
7-2SY: Rhinovirus (RV) and Respiratory Syncytial Virus (RSV) in Asthma | Peter Le Souëf (Australia)
10:45 - 11:05
7-3SY: Non-Viral Triggers of Asthma Exacerbation | Mika Mäkelä (Finland)
11:05 - 11:30
Discussion

10:00 - 10:30

Special Lecture 1: Bronchial Thermoplasty in Asthma
G.01 (HICC)
 Chairperson: Parameswaran Nair (Canada)
10:00 - 10:05
Welcoming Remarks
10:05 - 10:30
1-1SL: Speaker | Mario Castro (United States)

12:00 - 12:30

Keynote Lecture 3: A Holistic Approach to Severe and Complex Allergies
Hall 3 (HICC)
 Chairperson: Jyotsna Joshi (India)
12:00 - 12:05
Welcoming Remarks
12:05 - 12:30
3-1KN: Speaker | Ruby Pawankar (Japan)

12:30 - 13:00

Keynote Lecture 4: Freddy Hargreave Memorial Lecture: Sputum Inflammometry in the Management of Severe Asthma
Hall 3 (HICC)
 Chairperson: Zarir Udwadia (India)
12:30 - 12:35
Welcoming Remarks
12:35 - 13:00
4-1KN: Speaker | Parameswaran Nair (Canada)

13:00 - 14:00

Poster Session 2-1: Allergic Diseases of the Skin and Drug Allergies 1
Hall 4 (HICC)
 Chairpersons: Bee Wah Lee (Singapore) , Anne Goh (Singapore)
2001
2001: Amdosol – a Non-Steriod Drug for the Treatment of Chronic Atopic-Dermatitis | Vishwanath Kundur (India)
2002
2002: Association of Food and Drug Allergy with Anti-Tuberculosis Drug Related Hepatitis or Skin Reactions | Anoma Siribaddana (Sri Lanka)
2003
2003: Augmented Telomerase Activity and Reduced Telomere Length As A Disease Marker in Parthenium Induced Contact Dermatitis Patients | Alpana Sharma (India)
2004
2004: Clinical and Immunologic Characteristics of Allergen-Specific Immunotherapy in Children with Atopic Dermatitis | Tatiana Slavyanskaya (Russia)
2005
2005: Common Causes of Allergic Contact Dermatitis in Kuwait | Mona Al-Ahmad (Kuwait)
2006
2006: Cord Blood 25-Hydroxyvitamin D3 and Allergic Disease During Infancy | Anderson Phillip Jones (Australia)
2007
2007: Diclofenac Induced Leucopenia in 48-Year-Old Male Patient | Vesna Radovic (Serbia)
2008
2008: Gabriglobin Use in Treatment of Chronic Autoimmune Urticaria | Vladimir Aleshkin (Russia)
2009
2009: Gentamicin Induced Instability While Walking and Headache in 52–Old-Year Male Patient | Vesna Radovic (Serbia)
2010
2010: Intradermal Skin Testing with Cefazolin Regardless of the History of Hypersensitivity to Antibiotics | Jae-Woo Kwon (South Korea)
2011
2011: Is the Impact of Atopic Conditions On Children and Adolescents' Health Related Quality of Life Modified by Mental Health? Results From A Population-Based Cross-Sectional Study | C.J. Apfelbacher (Germany)
2012
2012: Is There Association Between Duration of Seasonal Allergic Rhinitis and Oral Allergy Syndrome? | Afshin Shirkani (Iran)
2013
2013: Longitudinal Analysis of Fecal Microbiota of Infants Followed-up for Eczema till 2 Years of Age | Gaik Chin Yap (Singapore)
2014
2014: Predictive Value of Clinical History in Suspicion of Quinolones Hypersensitivity | Luciana Kase Tanno (France)
2015
2015: Randomized Controlled, Double Blind Trial of Topical Twice Weekly Fluticasone Propionate Maintenance Treatment to Reduced Risk of Relapse in Mild or Moderate Atopic Dermatitis in Children | Elena Rubio (Spain)
2016
2016: Ranitidine Treatment in Preterm Infants and the Prevalence of Atopy At Two Years of Age | Than Soe (United Kingdom)
2017
2017: Rapid Desensitization for Delayed Reactions to Chemotherapy and Monoclonal Antibodies | Maria Aranzazu Vega Castro (Spain)
2018
2018: Risk Factors for Hypoproteinemia in Infantile Atopic Dermatitis | Geunhwa Park (South Korea)
Poster Session 2-2: Allergic Diseases of the Skin and Drug Allergies 2
Hall 4 (HICC)
 Chairpersons: Hiok Hee Chng (Singapore) , Connie Katelaris (Australia)
2019
2019: Higher Doses for Heavy Hives | Kiran Godse (India)
2020
2020: The Association Between DRESS and the Diminished Numbers of Peripheral B Lymphocytes and Natural Killer Cells | Mehtap Yazicioglu (Turkey)
2021
2021: Efficacy of Montelukast As Add-On Therapy in Patients with Chronic Idiopathic Urticaria | Sujoy Khan (United Kingdom)
2022
2022: Consensus Statement On Management of Urticaria in India | Kiran Godse (India)
2023
2023: Sulfamethoxazole / Trimethoprim Induced Leukocyte Count Decreased in 79–Old-Year Female Patient | Vesna Radovic (Serbia)
2024
2024: Autoserum Therapy in Autologous Serum Skin Test Positive Patients of Chronic Spontaneous Urticaria | Nidhi Sharma (India)
2026
2026: Immunologic Evaluation of the Patients with Cefaclor Hypersensitivity | Hye-Soo Yoo (South Korea)
2027
2027: Successful Treatment with Intravenous Immunoglobulin and Prednisolone Pulse Therapy of Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome | Arzu Didem Yalcin (Turkey)
2028
2028: Vitamin D Insufficiency in DRESS Syndrome | Young-Hee Nam (South Korea)
2029
2029: Prevalence and Factors of Food Allergy Among School-Age Children in Southern China | Mo Xian (China)
2030
2030: Validation of Cephalosporin Skin Test for Predicting Immediate Hypersensitivity: Interim Analysis | Hee-Bom Moon (South Korea)
2031
2031: Effectiveness of Autologous Serum Therapy in Patients of Chronic Urticaria: A Randomised, Single-Blind, Controlled Trial | Panchami Debbarman (India)
2032
2032: Epidemiological Study of a Specific Unit of Drugs Allergy Diagnosis. 20 Years Experience | Enrique Marti (Spain)
2033
2033: Metronidazole Skin Testing Associated with Systemic Reaction | Chwee Ying Tang (Singapore)
2035
2035: ALLERGEN CONTROL IN MANAGEMENT OF CHRONIC URTICARIA/ANGIOEDEMA (CUA) IN KENYA,EAST AFRICA | Tula Bowry (Kenya)
2036
2036: Exanthematous Drug Eruption to Prasugrel: A Case Report | Praveen Buddiga (United States)
Poster Session 2-3: Food Allergy and Anaphylaxis 1
Hall 4 (HICC)
 Chairpersons: Alessandro Fiocchi (Italy) , Suleiman Al-Hammadi (United Arab Emirates)
2037
2037: Emergency Department Management of Insect-Sting Allergic Reactions in a Community Hospital in the United States | M. Razi Rafeeq (United States)
2038
2038: Insect and Sting Allergy | Syed Arham Husain (India)
2039
2039: Bioinformatics Evaluation of New Proteins in Genetically Engineered Organisms and Novel Foods for Potential Risks of Food Allergy and Celiac Elicitation | Richard Goodman (United States)
2040
2040: Nutritional Status and Dietary Intake in Children with Cow's Milk Allergy | Maria Golebiowska Wawrzyniak (Poland)
2041
2041: Rush Oral Immunotherapy for Severe Food Allergy: One Year Follow up | Mayumi Sugimoto (Japan)
2042
2042: High Rates of Egg Reactivity in Infants with Eczema Randomised to Receive Egg Under 6 Months of Age | Jessica Metcalfe (Australia)
2043
2043: Poor Dilutional Linearity of Food Allergen Specific IgE Measurement by Immunocap in Samples with High Total IgE | Maaz Mohiuddin (United States)
2044
2044: Component Resolved Allergen Sensitization Profiles in Shrimp Allergy in the Tropics | Irenaeus Paul Chia (Singapore)
2045
2045: Highly Elevated IgE Antibodies to Vaccine Components in Influenza Vaccine-Associated Anaphylaxis in Japan | Mizuho Nagao (Japan)
2046
2046: Cloning and Characterization of the Gene for Acidic Thaumatin-Like Protein, an Important Allergen From Sapodilla Plum (Manilkara zapota) | Y.P. Venkatesh (India)
2047
2047: Anaphylaxis to Topically Applied Sodium Fusidate On Abrasions | Kangmo Ahn (South Korea)
2049
2049: Evolution of Food Allergy in a High Risk Population: The Canadian Asthma Primary Prevention Study (CAPPS) | Rishma Chooniedass (Canada)
2051
2051: Economic Burden of Anaphylaxis in the United States | Ray Wolf (United States)
Poster Session 2-4: Food Allergy and Anaphylaxis 2
Hall 4 (HICC)
 Chairpersons: Fares Zaitoun (Lebanon)
2052
2052: Vitamin D Insufficiency Is Associated with Challenge-Proven Food Allergy in Infants | Katie Allen (Australia)
2053
2053: New Diagnostic Algorithms That Will Reduce the Need for Oral Food Challenges | Katie Allen (Australia)
2054
2054: Easy-to-Use Severity Grading System for Treatment of Symptoms Induced by Oral Food Challenge | Noriyuki Yanagida (Japan)
2055
2055: Slow Specific Oral Tolerance Induction in Children with Hen's Egg Allergy; 3-Days On/4-Days off Schedule | Kentaro Mikami (Japan)
2056
2056: Clinical Cross-Reactivity of Major Food Allergens Among Children | Miho Hasegawa (Japan)
2057
2057: Protecting Food Allergic Consumers and Celiac Patients in India Requires Improvements in Diagnostic Accuracy, Patient Education, Food Handling and Labeling Practices | Richard Goodman (United States)
2058
2058: Elucidation of a 31 Kda Cross-Reactive Kidney Bean (Phaseolus vulgaris) Allergen | Komarla Nagendra (India)
2059
2059: Mild Symptoms Induced by Oral Food Challenge Are Not Always Associated with Failed Challenge Results | Taro Miura (Japan)
2060
2060: Oral Food Challenges Still the Most Reliable Test for a Diagnosis of Food Allergy | Meera Thalayasingam (Singapore)
2061
2061: Clinical Symptoms and Molecular Characterization of Hazelnut Allergy in Italian Children | Alessandro Fiocchi (Italy)
2062
2062: ‘Allergic Gastroenteropathy' in UK Children | Vijay Chakravarti (United Kingdom)
2063
2063: Identification of Foods Causing Hypersensitivity /Allergy Among School Children in Two Sub-Urban Schools in Colombo District, Sri Lanka | Y. Sarangee G. Wimalasiri (Sri Lanka)
2064
2064: Oral Food Challenges Still the Most Reliable Test for a Diagnosis of Food Allergy | Meera Thalayasingam (Singapore)
2065
2065: Food-Dependent Exercise-Induced Anaphylaxis in a Patient with Sensitization to Pork | Hyun Hee Lee (South Korea)
Poster Session 2-5: Immunotherapy 1
Hall 4 (HICC)
 Chairpersons: Pendakur Anand (India) , Nelson Rosario-Filho (Brazil)
2066
2066: A Study On Skin Prick Test Patterns of Atopic Patients Managed in a Tertiary Care Setting of Sri Lanka | Anoma Siribaddana (Sri Lanka)
2067
2067: Fel d 1 Peptide Antigen Desensitisation Safety and Efficacy in A Double-Blind, Placebo-Controlled Environmental Exposure Chamber Study | Roderick Peter Hafner (United Kingdom)
2068
2068: Immunomodulatory and Safety Profile of a Novel Anti-Allergic Vaccine Based On Allergens From Dermatophagoides Siboney and a Combination Adjuvant, in Sensitized Mice | Wendy Ramírez González (Cuba)
2069
2069: Multi-Center Study On the Performance Characteristics of Two Skin Test Devices - Comforten® and Mult-Test II® | Rohit K. Katial (United States)
2070
2070: S.L.I.T. RUSH Immunotherapy -Faster REACH to Maintenance Pleatu-India | Naren Pandey (India)
2071
2071: Strail Levels Decreased After Allergen- Subcutaneous Spesific Immunotherapy | Arzu Didem Yalcin (Turkey)
2072
2072: Therapeutic Effect and Higher Safety Profile for Allergic Asthma in Cuban Patients with Sublingual Immunotherapy Using Tropical Domestic Mite Allergen Vaccines | Raúl Lázaro Castro Almarales (Cuba)
2073
2073: Therapeutic Effect of Mite Allergen Vaccines by Subcutaneous Route in Allergic Cuban Asthmatic Patients | Raúl Lázaro Castro Almarales (Cuba)
2074
2074: Tolerability of Sublingual Immunotherapy with Tropical Mite Allergen Vaccines Using Different Dosing Schedules in Asthmatic Children | Raúl Lázaro Castro Almarales (Cuba)
2075
2075: Towards A Pan Anti-Allergy Vaccine | Sari Sabban (United Kingdom)
Poster Session 2-6: Immunotherapy 2
Hall 4 (HICC)
 Chairpersons: Thomas B. Casale (US) , Ignacio J. Ansotegui (Spain)
2076
2076: A Controlled Study of Delta Inulin-Adjuvanted Honey Bee Venom Immunotherapy | Robert Heddle (Australia)
2077
2077: Allergen Specific Immunotherapy in Allergic Conjunctivitis Due to Dust Mite | Sanjay Pawar (India)
2078
2078: Allergen-Specific Oral Immunotherapy for Peanut Allergy: A Cochrane Systematic Review | Ulugbek Nurmatov (United Kingdom)
2079
2079: Comparison of House Dust Mite Specific IgE and IgG4 Between Patients Receiving Rush Immunotherapy and Conventional Immunotherapy | Ji-Ho Lee (South Korea)
2080
2080: Fel d 1 Derived Peptide Antigen Desensitisation Results in A Persistent Treatment Effect On Symptoms of Cat Allergy 1 Year After 4 Doses | Roderick Peter Hafner (United Kingdom)
2081
2081: Immunotherapy Unit: Start and Monitoring | M. Socorro Pérez-Bustamante (Spain)
2082
2082: Long Term Prevention of Asthma and Rhinitis in Children with Atopic Dermatitis Four-Year After Discontinuation of Sublingual Immunotherapy | Giovanni Passalacqua (Italy)
2083
2083: Safety of Accelerated Schedules of Cluster Allergen Immunotherapy with House Dust Mites in Sixty Five Patients with Perennial BR.Asthma | Pooran Chand Kathuria (India)
2084
2084: Study of Efficacy of Sublingual Immunotherapy [Slit]in Cases of Chronic Allergic Rhinitis | Subir Jain (India)
Poster Session 2-7: Rhinitis, Sinusitis and Ocular Disease
Hall 4 (HICC)
 Chairpersons: Claudia Ivonne Gallego (Mexico) , Achal Gulati (India)
2085
2085: Prevalence of Allergic Rhinitis in Urban School Children, Jaipur City, India | Abhishek Saini (India)
2086
2086: Nox4 Mediates Hypoxia-Stimulated Myofibroblast Differentiation in Nasal Polyp-Derived Fibroblasts | Heung-Man Lee (South Korea)
2087
2087: Usefulness of Impulse Oscillometry and Fractional Exhaled Nitric Oxide in Children with Eosinophilic Bronchitis | Kyu-Earn Kim (South Korea)
2088
2088: Evaluation of Blood Markers for Determination of Atopy in Indian Patients with Symptoms of Respiratory Allergy | Vattikonda Sathavahana Chowdary (India)
2089
2089: Evaluating the Quality and Contents of Paranasal Sinusitis-Related Information On the Web-Sites in Western Physician and Eastern Physician | Yong-Dae Kim (South Korea)
2090
2090: Allergy-the Natural Immunotherapy | Syed Arham Husain (India)
2091
2091: The MSYPQ: Repeatability and Applicability to Rhinitis/Rhinosinusitis | Amtul Salam Sami (United Kingdom)
2092
2092: The Msnot-20 Questionnaire: Repeatability and Disease Analysis of Rhinitis/Rhinosinusitis | Amtul Salam Sami (United Kingdom)
2093
2093: Effect of Intranasal Steroid On Cough Symptom in Patients with Upper Airway Cough Syndrome | Jeong-Eun Kim (South Korea)
2094
2094: Study of Incidence of Chronic Allergic Rhinitis in Different Age Groups,Sex Prevalance and Type of Allergen Responsible for Chronic Allergic Rhinitis in Central India | Subir Jain (India)
2095
2095: Inhibitory Effect of Ginsenoside Rg1 On Extracellular Matrix Production Via Extracellular Signal-Regulated Protein Kinase/Activator Protein 1 Pathway in Nasal Polyp-Derived Fibroblasts | Sung Moon Hong (South Korea)
2096
2096: Clinical Efficacy of Desloratadine Therapy in Children with Persistent Form of Allergic Rhinitis and Its Impact On Asthma Symptoms | Ivan Shishimorov (Russia)
2097
2097: Dentomaxilofacial Disorders in Children with Allergic Rhinitis | Claudia Ivonne Gallego (Mexico)
2098
2098: Exhaled NO May Predict Development of Allergic Rhinitis in Children with Asthma | Yeong Ho Rha (South Korea)
2099
2099: Plants Remedies for Treatment of Inflammatory Diseases in the United States of America: Knowledge Among the Inhabitants of Los Angeles within California | Md. Ariful Haque Mollik (United States)
2100
2100: New Approach to Treat Allergic Rhinitis With Vitamin E, Cod Liver Oil and Vitamin C with Use Nasal steroidal Spray | Geetendra Singh Dhanawat (India)
2102
2102: The Activities of Allergy Pot as a Patient Group in Japan: Developing Treatment Guidelines | Mariko Kuriyama (Japan)
2103
2103: Comparative Allergen Profile In Krishna - Godavari Region | Hari Kishan Gonuguntla (India)

14:00 - 15:30

Plenary Session 4: Anaphylaxis
Hall 3 (HICC)
 Chairpersons: Mario Sanchez Borges (Venezuela) , Yin Jia (China)
14:00 - 14:05
Welcoming Remarks
14:05 - 14:30
4-1PS: Mechanisms of Anaphylaxis | Richard F. Lockey (United States)
14:30 - 14:55
4-2PS: 2012 Update: WAO Anaphylaxis Guidelines | F. Estelle R. Simons (Canada)
14:55 - 15:20
4-3PS: Anaphylaxis, Asthma and Pregnancy | Sandra Gonzalez-Diaz (Mexico)
15:20 - 15:30
Discussion

15:45 - 17:30

Company Sponsored Symposium 2: MSD: Asia Pacific Perspectives in Asthma Management
Hall 1 (HICC)
 Chairperson: Randeep Guleria (India)
15:45 - 15:50
Welcoming Remarks
15:50 - 16:15
2-1CSS: Asthma Insight Management (AIM) Survey: Challenges & Unmet Needs | Sandeep Salvi (India)
16:15 - 16:40
2-2CSS: Diagnostic & Treatment of Childhood Asthma | H. Paramesh (India)
16:40 - 17:05
2-3CSS: Bridging Gap Between Patient Perceptions & Realities in Adult Asthma | Hae-Sim Park (South Korea)
17:05 - 17:30
Panel Discussion
Symposium 10: Allergy Diagnostics: Current and Future Perspectives
Hall 3 (HICC)
 Chairpersons: Mübeccel Akdis (Switzerland) , Syed Mohammed Hasnain (Saudi Arabia)
15:45 - 15:50
Welcoming Remarks
15:50 - 16:10
10-1SY: In-Vivo and In-Vitro Diagnostic Tests | Ignacio J. Ansotegui (Spain)
16:10 - 16:30
10-2SY: Molecular Characterization of Aeroallergens | Wayne Thomas (Australia)
16:30 - 16:50
10-3SY: Molecular Characterization of Food Allergens | Wesley Burks (United States)
16:50 - 17:10
10-4SY: Molecular Allergology | G. Walter Canonica (Italy)
17:10 - 17:30
Discussion
Symposium 11: Indian College of Allergy, Asthma and Applied Immunology (ICAAI): Highlights of Airway Diseases in India
Hall 2 (HICC)
 Chairpersons: Ashok Shah (India) , Anand B Singh (India)
15:45 - 15:50
Welcoming Remarks
15:50 - 16:10
11-1SY: Epidemiology of Airway Diseases, Asthma and COPD in India | S.K. Jindal (India)
16:10 - 16:30
11-2SY: Genetics of Asthma in India | Balram Ghosh (India)
16:30 - 16:50
11-3SY: Impact of Indoor and Outdoor Pollution on Allergic Airway Disease in India | S.K. Chhabra (India)
16:50 - 17:10
11-4SY: Pediatric Asthma in India | H. Paramesh (India)
17:10 - 17:30
Discussion
Symposium 12: Precision Treatments in Allergic Disorders
Hall 5 and 6 (HICC)
 Chairpersons: Jonathan Bernstein (US) , Mario Castro (US)
15:45 - 15:50
Welcoming Remarks
15:50 - 16:10
12-1SY: Update on Anti-IgE | Stephen T. Holgate (United Kingdom)
16:10 - 16:30
12-2SY: Update on Anti-Cytokines | Lanny J. Rosenwasser (United States)
16:30 - 16:50
12-3SY: Designer Drugs: Antibodies to Inhibitory Receptors | Francesca Levi-Schaffer (Israel)
16:50 - 17:10
12-4SY: New Imaging Approaches to Asthma | Mario Castro (United States)
17:10 - 17:30
Discussion

Sunday, 9 December 2012

Thursday | Friday | Saturday | Sunday | top

07:45 - 10:30

1965: Session 1
G.03 (HICC)
07:45 - 08:00
Welcoming Remarks
08:00 - 08:30
Food Allergy: Pathophysiology, Diagnosis and Management | Susan Prescott (Australia)
08:30 - 09:00
Contact Dermatitis: Pathophysiology, Diagnosis and Management | Richard Weber (United States)
09:00 - 09:30
Drug Allergy: Pathophysiology, Diagnosis and Management | Mario Sanchez Borges (Venezuela)
09:30 - 10:00
Pediatric Asthmas: Diagnosis and Treatment | Michael Blaiss (United States)
10:00 - 10:30
Adult Asthma: Diagnosis and Treatment | Stephen T. Holgate (United Kingdom)

08:00 - 09:30

Plenary Session 5: Skin Allergies
Hall 3 (HICC)
 Chairpersons: Sandra Gonzalez-Diaz (Mexico) , Menachem Rottem (Israel) , Meenu Singh (India)
08:00 - 08:05
Welcoming Remarks
08:05 - 08:30
5-1PS: Update on Chronic Urticaria | Mario Sanchez Borges (Venezuela)
08:30 - 08:55
5-2PS: Severe Atopic Dermatitis: A Challenge for the Clinician | Thomas Bieber (Germany)
08:55 - 09:20
5-3PS: How to Deal with Refractory Urticaria | Sarbjit Saini (United States)
09:20 - 09:30
Discussion

08:30 - 10:00

General Practitioner Program 1: Objective Assessment of Upper Airway Diseases: Hands-on Rhinolaryngoscopy and Nasal Challenge Tests
G.01 (HICC)
08:30 - 08:35
Welcoming Remarks
08:35 - 08:55
1-1GP: Nasal Examination for Upper Airway Disease | Manabu Nonaka (Japan)
08:55 - 09:15
1-2GP: Imaging | Claus Bachert (Belgium)
09:15 - 09:35
1-3GP: Nasal Endoscopy: Practical Aspects | Nishit Shah (India)
09:35 - 10:00
Discussion

10:30 - 11:30

Poster Session 3-1: Allied Health
Hall 4 (HICC)
 Chairpersons: Barnali Bhattacharya (India) , Dana Wallace (US)
3001
3001: Dose Treatment of Gasteroesophageal Reflux Disease in Patients with Allergic Rhinitis Improve Allergic Symptoms? | Afshin Shirkani (Iran)
3002
3002: Aero-Allergen Sensitivity Among Patients Suffering From Bronchial Asthma in Bangalore, Karnataka, India | Giriyanna Gowda (India)
3003
3003: The Relation of Cachexia to the Risk of Hospitalization with Fixed Airway Obstruction | June-Hyuk Lee (South Korea)
3004
3004: Pulmonary Function TESTS: A Study of 1000 Normal Children | Krishna Bihari Gupta (India) Krishna Bihari Gupta (India)
3005
3005: Vidal - Fernand - Samter Syndrom - Interdisciplinary Approach | Daniela Neacsu (United States)
3006
3006: Homeopathy in Treating Allergic Rhinitis – an Interventional Pilot Study | Shubhamoy Ghosh (India)
3007
3007: The Biomarker of Sublingual Immune Therapy | Masafumi Sakashita (Japan)
3008
3008: Comparison of Anti-Allergic Effect of Pneumococcal Conjugated Vaccine and Pneumococcal Polysaccharide Vaccine in a Murine Model of House Dust Mite Allergic Rhinitis | Soo Whan Kim (South Korea)
3009
3009: Comparative Assessment of Dental Caries Experience, Oral Hygiene Status, Gingival Health Status, Salivary Streptococcus Mutans Count and Lactobacillus Count Between Asthmatic and Non-Asthmatic Children Aged Between 5-12 Years in Davangere City, Karnataka, | Usha Venkatesh (India)
Poster Session 3-2: Basic and Clinical Immunology 1
Hall 4 (HICC)
 Chairpersons: Francesca Levi-Schaffer (Israel)
3010
3010: The RNA-Binding Protein Hur Coordinately Regulates GATA-3 and TH2 Cytokine Gene Expression in Dose Dependent Manner | Ulus Atasoy (United States)
3011
3011: Evaluation of Selected Parameters of Cellular Immunity At Diagnosis in Children with Osteosarcoma | Katarzyna Markiewicz (Poland)
3012
3012: Per a 10 Favors Dcs Type 2 Polarizations by CD40 Cleavage and IL-12 Suppression in Cockroach-Sensitive Patients | Chhavi Goel (India)
3013
3013: Resource Limited Estimation of HIV-1 Viral Load From CD4 Cell Count Using Coupled Bacterial Foraging/Jumping Frogs Algorithm | Kamalanand Krishnamurthy (India)
3014
3014: Pollen Lipid Can Not Stimulate iNKT Cells in Pollen Sensitized Patients | Mohammad Fereidouni (Iran)
3015
3015: Nonspecific Defense Factors in Premature Infants with Pneumonia | Furkat Muhitdinovich Shamsiev (Uzbekistan)
3016
3016: Successful Desensitization to Oxaliplatin for Metastatic Colorectal Carcinoma | Praveen Buddiga (United States)
Poster Session 3-3: Basic and Clinical Immunology 2
Hall 4 (HICC)
 Chairpersons: Christina West (Sweden) , Harald Renz (Germany)
3017
3017: A Functional Polymorphism in IL-5 Receptor Alpha May Influence Asthma Severity in Patients with Aspirin-Exacerbated Respiratory Disease | Purevsuren Losol (South Korea)
3018
3018: Immunocap Vs. Skin Prick Testing for Inhalent Allergens | Prem Kumar (United States)
3019
3019: Gamma Interferon Release Assay for Diagnosis of Latent Tuberculosis- Comparison with TB Skin Test | Prem Kumar (United States)
3020
3020: Fish Oil Supplementation in Early Infancy Modulates Developing Infant Immune Responses but Not Clinical Allergy | Manori Amarasekera (Australia)
3021
3021: Inhibitory Action of Levocetirizine Hydrochloride On Eosinophil Activation in Vitro | Atsuko Furuta (Japan)
3022
3022: Inhibitory Action of Fexofenadine Hydrochloride On Mast Cell Activation in Vitro | Miyuki Suzuki (Japan)
3023
3023: Influence of Fexofenadine Hydrochloride On Uteroglobin Production From Nasal Epithelial Cells in Vitro and in Vivo | Kenichi Kanai (Japan)
3024
3024: First Evidence for Epigenetic Disruption in T-Cells From Children with Food Allergy | David Jim Martino (Australia)
3025
3025: Suppression of Eosinophil Activation by Levocetirizine Hydrochloride in Vivo | Kenichiro Kawaguchi (Japan)
3026
3026: Kartagener's Syndrome | Saikrishna Singaraju (India)
3027
3027: Group of Immune Factors Studied in Relation to Early Development of Allergic Symptoms in an Indian Subpopulation At One Year of Age | Pooja Soneja (India)
3028
3028: Interaction of DNA Methylation and Genetic Variants of IL13 Is Associated with FEV1/FVC and Bhr | Veeresh K. Patil (United Kingdom)
3029
3029: Secretory Leukocyte Protease Inhibitor Plays an Important Role in the Regulation of Eye Inflammation and Wound Healing | Andrés Ricardo Grenat (Argentina)
3030
3030: Subcutaneous Immunoglobulin Therapy: An Option for Patients Who Have Experienced Thrombotic Complications with Intravenous Therapy | Leslie Anne Moss (Canada)
3031
3031: THE CORRELATION BETWEEN SERUM PROTEOMICS PATTERNS OF STRAIL AND CXCL8 WITH FDG-PET/CT FINDINGS IN BEVACIZUMAB TREATED COLON CANCERS | Arzu Didem Yalcin (Turkey)
3032
3032: 18FDG-PET/CT Findings (suv-max) are Correlated with Survival in Stage-4 Squamous cell carcinoma | Arzu Didem Yalcin (Turkey)
3033
3033: Structural Analyses and Allergenicity Prediction of Sapodilla (Manilkara zapota) Acidic Thaumatin-like Protein by Bioinformatics | Y.P. Venkatesh (India)
3034
3034: Peculiarities of Parameters Immune System in Juvenile Rheumatoid Arthritis | Diloram Abdullaevna Musakhodjaeva (Uzbekistan)
3035
3035: The Imbalance of Parameters of Immune System in Children with Nosocomial Pneumonia and Dysbiosis | Syayra Ibragimova (Uzbekistan)
3036
3036: Investigation of Peripheral Follicular Helper T Cells in Primary Sjögren's Syndrome | Krisztina Szabo (Hungary)
Poster Session 3-4: Health Outcomes, Education, Healthcare Delivery and Quality 1
Hall 4 (HICC)
 Chairpersons: João Tebyrica (Brazil) , Jung-Won Park (South Korea)
3037
3037: Allergy Immunotherapy Quality of Life and Perceived Efficacy Opinion Survey | Praveen Buddiga (United States)
3038
3038: The Relation of Strail Levels and Quality of Life in Omalizumab Using Severe Persistent Allergic Asthma Patients | Arzu Didem Yalcin (Turkey)
3039
3039: A Comparative Review of the Burden, Prevalence, Knowledge about Allergic Rhinitis Between the US and India | Muntajibuddin Arif Ahmed (India)
3040
3040: Occurrence and Effects of Nasal Polyps in Patients with Bronchial Asthma and/or Allergic Rhinitis | Swati Behera (India)
3041
3041: Smoking Habit Behaviour in Adolescents | Belkis López González (Cuba)
3042
3042: Quality of Life in Children with Atopic Dermatitis and Its Relationship with Disease Severity | Vivek Rungta (India)
3043
3043: Randomized, Double Blind Comparative Study to Assess Health Related Quality of Life with Mometasone & Formoterol Versus Fluticasone & Formoterol Dry Powder Inhaler (DPI) in the Treatment of Mild to Moderate Persistent Asthma | B.G. Parasuramalu (India)
3044
3044: Developing A Quality of Life Questionnaire for Indian Asthmatic Children (QOLQI) Below Age 5 Years - A Pilot Study | Asha Pherwani (India)
3045
3045: Questionnaire Survey of Patients with Allergic Disorders in Bangalore, India | Eash Hoskote (India)
3046
3046: Impact of Obstructive Sleep Apnoea On Parameters of Metabolic Syndrome | Vinaya Karkhanis (India)
3047
3047: What Do Patients Think about Asthma-Specific Quality of Life Questionnaires? Qualitative Interview Study in the United Kingdom | C.J. Apfelbacher (United Kingdom)
3048
3048: From Uterus to University: Recruitment and Retention of a Primary Prevention Birth Cohort | Brenda Gerwing (Canada)
3049
3049: HEALTH IN SUSTAINABLE DEVELOPMENT: USABILITY OF HEALTH INDICATORS IN URBAN PLANNING, CASE STUDY OF ANTALYA METROPOLITAN MUNICIPALITY | Arzu Didem Yalcin (Turkey)
3050
3050: A Survey of Severe Allergic Symptoms Among Children In a Disaster-hit Area: Challenge of Tohoku Medical Megabank Organization | Mami Ishikuro (Japan)
Poster Session 3-5: Health Outcomes, Education, Healthcare Delivery and Quality 2
Hall 4 (HICC)
 Chairpersons: Peter Le Souëf (Australia) , Yuzhi Chen (China)
3051
3051: Profiles of Diagnosis and Treatment of Asthma in the Public Health System in Brazil | Ana Carla S. Araujo (Brazil)
3052
3052: IL-17, IL-8, TGF-Beta and GMCSF Levels in Patients with Allergic Asthma: Its Relation to Omalizumab Treatment | Arzu Didem Yalcin (Turkey)
3053
3053: Is It Necessary to Re-Evaluate the Airway Hyperresponsiveness While in the Treatment of Mild Asthma? | Jaechun Lee (South Korea)
3054
3054: Modified Health Behaviour & Education Causing Allergy and Obesity | Syed Arham Husain (India)
3055
3055: Relation Between Gastroesophageal Reflux Disease and Asthma | Daymee Novoa Selles (Cuba)
3056
3056: Constructed Supporting Program Improves Asthma Treatment Outcomes in Children | Jing-Long Huang (Taiwan)
3057
3057: Randomized, Double Blind Comparative Study to Assess Safety, Efficacy with Mometasone & Formoterol Versus Fluticasone & Formoterol Dry Powder Inhaler (DPI) in the Treatment of Mild to Moderate Persistent Asthma | Dr Sathish Chandra MR (India)
3058
3058: The First Beijing Olympic Games of Asthmatic Children | Yuzhi Chen (China)
3059
3059: Relation Between Body Mass Index and Control of Bronchial Asthma Among Egyptian Adults with Asthma | Mohamed Helmi Zidan (Egypt)
3060
3060: Assesement of Parameters of Six-Minute Walk Test (6MWT) in Healthy Young Subjects | Prasad Eswara Chelluri (India)
3061
3061: Usage of Electronic Medical Record in A Tertiary Care Institute: A Questionnaire Based Study | Dipti Gothi (India)
3062
3062: Snake-Bites Among Hospitalized Patients in the Shaheed Ziaur Rahman Medical College and Hospital Bogra Bangladesh | Md. Ariful Haque Mollik (Bangladesh)
3063
3063: Cost-Effectiveness of Immunotherapy for Children with Atopic Dermatitis | Tatiana Slavyanskaya (Russia)

11:00 - 12:30

General Practitioner Program 2: Spirometry and Inhalation Devices
G.01 (HICC)
11:00 - 11:05
Welcoming Remarks
11:05 - 11:25
2-1GP: Spirometry | Monica Barne (India)
11:25 - 11:45
2-2GP: Inhalation Devices | Michael Blaiss (United States)
11:45 - 12:05
2-3GP: Inhalation Devices in India | K.S. Satish (India)
12:05 - 12:30
Discussion

11:30 - 13:15

Symposium 15: Small Airways Disease
Hall 5 and 6 (HICC)
 Chairpersons: Manori Amaraskera (Sri Lanka) , Mika Mäkelä (Finland) , Virendra Singh (India)
11:30 - 11:35
Welcoming Remarks
11:35 - 11:55
15-1SY: Particle Deposition and Pharmacotherapy | Lanny J. Rosenwasser (United States)
11:55 - 12:15
15-2SY: Pathophysiology of the Small Airways | Rohit K. Katial (United States)
12:15 - 12:35
15-3SY: Respiratory Function in Small Airways and Asthma | Thomas B. Casale (United States)
12:35 - 12:55
15-4SY: Optimal Assessment of asthma Control in Clinical Practice: Is there a Role for Biomarkers? | Stanley Fineman (United States)
12:55 - 13:15
Discussion

11:30 - 13:00

Company Sponsored Symposium 3: MSD: Upper Airway Inflammatory Disease: Opportunity & Challenges
Hall 1 (HICC)
 Chairperson: K.R. Meghanadh (India)
11:30 - 11:35
Welcoming Remarks
11:35 - 12:00
3-1CSS: Management and Structured Approach for Allergic Rhinitis Patient in Clinical Setting | Neelam Vaid (India)
12:00 - 12:25
3-2CSS: Management of Rhinosinusitis & Nasal Polyps 2012 | Nishit Shah (India)
12:25 - 12:50
3-3CSS: Diagnostic Tools in Rhinology: AR, Nasal Polyposis & Rhinosinusitis | E.V. Raman (India)
12:50 - 13:00
Panel Discussion
Symposium 13: HIGHLIGHT ON IMMUNOTHERAPY 1
Hall 3 (HICC)
 Chairpersons: Wesley Burks (US) , Hee-Bom Moon (South Korea)
11:30 - 11:35
Welcoming Remarks
11:35 - 11:55
13-1SY: Mechanisms of Immunotherapy | Cezmi Akdis (Switzerland)
11:55 - 12:15
13-2SY: Sublingual Immunotherapy | G. Walter Canonica (Italy)
12:15 - 12:35
13-3SY: Subcutaneous Immunotherapy: When and How to Start | Giovanni Passalacqua (Italy)
12:35 - 13:00
Discussion
Symposium 14: Disease Prevention in the New Millennium: Allergy in the Context of Other NCDs
Hall 2 (HICC)
 Chairpersons: AG Ghoshal (India) , John Sinn (Australia)
11:30 - 11:35
Welcoming Remarks
11:35 - 11:55
14-1SY: The Central Role of the Immune System in the Global Burden NCDs | Harald Renz (Germany)
11:55 - 12:15
14-2SY: Exploring Common Risk Factors in the Prevention of Allergy and Other NCDs | Susan Prescott (Australia)
12:15 - 12:35
14-3SY: Global Strategies to Combat the Allergic Disease Burden | Tari Haahtela (Finland)
12:35 - 13:00
Discussion

13:00 - 14:30

1966: Session 3
G.03 (HICC)
13:00 - 13:30
Anaphylaxis: Pathophysiology, Diagnosis and Management | Stanley Fineman (United States)
13:30 - 14:00
Diagnostic Skin Testing & Subcutaneous Allergy Immunotherapy | Dana Wallace (United States)
14:00 - 14:30
Atopic Dermatitis: Pathophysiology, Diagnosis and Management | Sandra Gonzalez-Diaz (Mexico)

13:30 - 15:30

General Practitioner Program 3: Improving Patient’s Asthma Control and Quality of Life
G.01 (HICC)
13:30 - 13:35
Welcoming Remarks
13:35 - 13:55
3-1GP: Compliance and Treatment Adherence | Michael Blaiss (United States)
13:55 - 14:15
3-2GP: Implementation of Guidelines and Assessing Asthma Control | Raja Dhar (India)
14:15 - 14:35
3-3GP: Differentiating Asthma from COPD | Vijai Kumar Ratnavelu (India)
14:35 - 14:55
3-4GP: How to Improve Treatment Adherence by Better Patient Education | Barnali Bhattacharya (India)
14:55 - 15:30
Discussion

13:30 - 14:00

Keynote Lecture 5: Pharmacogenetics
Hall 3 (HICC)
 Chairperson: Koichiro Asano (Japan)
13:30 - 13:35
Welcoming Remarks
13:35 - 14:00
5-1KN: Speaker | Elliot Israel (United States)

15:00 - 16:45

Symposium 16: HIGHLIGHT ON IMMUNOTHERAPY 2
Hall 3 (HICC)
 Chairpersons: João Tebyrica (Brazil)
15:00 - 15:05
Welcoming Remarks
15:05 - 15:25
16-1SY: Immunomodulators - Anti-IgE mAb | Thomas B. Casale (United States)
15:25 - 15:45
16-2SY: Immunotherapy in the Pediatric Population | Michael Blaiss (United States)
15:45 - 16:05
16-3SY: Subcutaneous Immunotherapy and Sublingual Immunotherapy in Asthmatics | Roy Gerth Van Wijk (Netherlands)
16:05 - 16:25
16-4SY: Insect Immunotherapy | Richard Weber (United States)
16:25 - 16:45
Discussion
Symposium 17: Microbiome
Hall 2 (HICC)
 Chairpersons: Amir Hamzah Abdul Latiff (Malaysia) , Wayne Thomas (Australia)
15:00 - 15:05
Welcoming Remarks
15:05 - 15:25
17-1SY: Defining the Microbiome in the Healthy and Diseased Lung | Stephen T. Holgate (United Kingdom)
15:25 - 15:45
17-2SY: The Early Life Microbiome in the Emergence of Allergic Disease in Children | Christina West (Sweden)
15:45 - 16:05
17-3SY: Model Systems to Investigate Microbial Interactions in the Protection Against Allergy | Harald Renz (Germany)
16:05 - 16:25
17-4SY: The Role of Staphylococci in the Emergence of Chronic Nasal and Lower Airways Disease | Claus Bachert (Belgium)
16:25 - 16:45
Discussion
Symposium 18: Chronic Rhinosinusitis
Hall 5 and 6 (HICC)
 Chairpersons: Ho Joo Yoon (South Korea) , Luo Zhang (China)
15:00 - 15:05
Welcoming Remarks
15:05 - 15:25
18-1SY: Chronic Rhinosinusitis is Not One Disease: What You Should Know About Inflammation | Claus Bachert (Belgium)
15:25 - 15:45
18-2SY: Medical Therapy of CRS With and Without Nasal Polyps, From Evidence to Innovation | Peter W. Hellings (Belgium)
15:45 - 16:05
18-3SY: Surgical Therapy of CRS With and Without Nasal Polyps | Robert Naclerio (United States)
16:05 - 16:25
18-4SY: Difficult Cases of CRS | Achal Gulati (India)
16:25 - 16:45
Discussion

15:00 - 16:15

1967: Workshop A
G.03 (HICC)
15:00 - 16:15
Anaphylaxis | Stanley Fineman (United States)
1968: Workshop B
G.06 (HICC)
15:00 - 15:35
Prick and Intradermal Skin Testing | Dana Wallace (United States)
15:35 - 16:10
Prick and Intradermal Skin Testing | Richard Weber (United States)

16:45 - 17:50

Symposium 19: HIGHLIGHT ON IMMUNOTHERAPY 3
Hall 3 (HICC)
 Chairpersons: Karnen Baratawidjaja (Indonesia) , Giovanni Passalacqua (Italy)
16:45 - 16:50
Welcoming Remarks
16:50 - 17:10
19-1SY: Identification of Eligible Patients for Immunotherapy | G. Walter Canonica (Italy)
17:10 - 17:30
19-2SY: Prevention | Hugo Van Bever (Singapore)
17:30 - 17:50
Discussion